Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize Performance

The 2019 coronavirus (COVID-19) pandemic revealed the urgent need for the acceleration of vaccine development worldwide. Rapid vaccine development poses numerous risks for each category of vaccine technology. By using the Risklick artificial intelligence (AI), we estimated the risks associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Quentin, Borisov, Nikolay, Alvarez, David Vicente, Ferdowsi, Sohrab, von Meyenn, Leonhard, Teodoro, Douglas, Amini, Poorya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Digital Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593331/
https://www.ncbi.nlm.nih.gov/pubmed/34796360
http://dx.doi.org/10.3389/fdgth.2021.745674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593331/
https://www.ncbi.nlm.nih.gov/pubmed/34796360
http://dx.doi.org/10.3389/fdgth.2021.745674

Ejemplares similares